Shetty Reshma P.'s Form 4 filing
Ginkgo Bioworks Holdings, Inc. (DNA) · filed Nov 16, 2022
- Accession no.
- 0000899243-22-036025
- Filed
- Nov 16, 2022
- Trade date
- Nov 14-15, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $2.20M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shetty Reshma P.CIK 0001873523 | Director, Officer (See remarks), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2022 | Class A Common Stock | SSaleDisposed | −208,633 | $2.72 | −$567,481.76 | 21,375,162 | Direct | Duplicate filing |
| Nov 14, 2022 | Class A Common Stock | SSaleDisposed | −208,632 | $2.72 | −$567,479.04 | 21,375,164 | Indirect | Duplicate filing |
| Nov 15, 2022 | Class A Common Stock | SSaleDisposed | −212,443 | $2.51 | −$533,231.93 | 21,162,719 | Direct | Duplicate filing |
| Nov 15, 2022 | Class A Common Stock | SSaleDisposed | −212,443 | $2.51 | −$533,231.93 | 21,162,721 | Indirect | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
President, COO & Founder